Effect of Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA) Supplementation on Hot Flashes in Menopausal Women: A Randomized, Double - Blind, Placebo- Controlled Clinical Trial

M. Hajifaraji,R. Moghadam,S. Beheshti,H. Soori

Abstract:Background: Hot Flash is one of the compliance that impact on quality of life in menopausal women. This study investigated the effects of Eicosapentaenoic acid (EPA), and Docosahexaenoic acid (DHA) fatty acid supplementation on Hot Flashes in menopausal women. Materials and Methods: This is a Randomised, Double- Blind, Placebo- Controlled Clinical Trial study, on 83 menopause Women between 45-60 years old that had Inclusion criteria, and were randomly assigned to clinical group Ecosanoids or control group (placebo). Capsules of containing 300 mg (EPA) and (DHA) or placebo were prescribed to the participents for eight weeks one time per day. Of the 83 patients enrolled, 68 completed the study (Eicosanoid supplement, n=34; placebo; n = 34). Data collection method was demographic questionnaire, diary self report and food frequency questionnaire (FFQ). Data were analyzed by spss18: T tests, Chi-squared, Friedman and Mann-Whitney tests. Results: After 8 weeks intervention, There was significant difference HF frequency (P=0.003) between two groups. There was no significant difference in HF intensity between two groups (P=0.2) but it was significant reduction in intensity within two groups (P=0.003). Conclusions Eicosapentaenoic acid (EPA), and Docosahexaenoic acid (DHA) Supplementation affected on reduction of HF frequency and intensity, without significant difference on severity of HF. (R, Moghadam, S.Najafi. Effect of Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA) Supplementation on Hot Flashes in Menopausal Women: A Randomized, Double - Blind, Placebo- Controlled Clinical Trial. N Y Sci J 2014;7(7):37-42). (ISSN: 1554-0200). http://www.sciencepub.net/newyork. 6

Medicine